Brand Name: Infusor SV and LV Elastomeric Infusion Devices. Indicated for the intravenous administration of medications.
Published July 3, 2013 · Recall initiated: June 7, 2013
Summary
FDA records medical device Class II recall Z-1600-2013, published July 3, 2013 and initiated June 7, 2013. Recalling firm: Baxter Healthcare Corp.; Status: Terminated; Reported quantity: 3,255,096 total; Lot: Product Codes: 2C1008KP, 2C1009KP, 2C1063KP, 2C1087KP, 2C1156KP, 2C1700KP, 2C1702KP Lot Codes: 10F032 10G056 10H066 10J047 10K024 10K087 10M021 10M088 10F059 10F069 10F070 10G029 10G043 10G062 10G067 10H032 10H093 10J049 10J060 10J089 10J105 10K028 10K030 10K038 10K088 10K096 10K102 10M025 10M044 10F022 10F068 10F072 10G030 10G045 10G046 10G047 10G050 10G051 10H016 10H018 10H087 10H094 10J053 10J058 10J062 10J102 10K026 10K035 10K039 10K086 10M023 10M040 10M043 10M045 10F020 10F087 10H086 10H095 10J017 10J020 10J056 10J068 10K021 10K029 10K031 10K081 10K105 10M017 10M039 10J052 10K098 10F064 10H044 10K022 10K042 10F024 10F025 10F033 10F055 10F062 10F063 10F065 10H005 10H030 10H042 10J015 10J019 10J061 10J065 10K032 10K037 10K095 10M030 10M087 10M098 10M099 10M100 Expiration Date: 06/30/13. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Baxter Healthcare Corporation (Baxter) is issuing an Urgent Product Recall for the products listed above due to an increase in rupture complaints. Baxter has implemented product and process improvements which have substantially improved product quality. Complaint rates for ruptures have since decreased. Baxter wants to ensure that no affected product remains in the field.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Baxter Healthcare Corp.
- Distributor
- Distributed Nationwide and in Puerto Rico.
- Lot
- Product Codes: 2C1008KP, 2C1009KP, 2C1063KP, 2C1087KP, 2C1156KP, 2C1700KP, 2C1702KP Lot Codes: 10F032 10G056 10H066 10J047 10K024 10K087 10M021 10M088 10F059 10F069 10F070 10G029 10G043 10G062 10G067 10H032 10H093 10J049 10J060 10J089 10J105 10K028 10K030 10K038 10K088 10K096 10K102 10M025 10M044 10F022 10F068 10F072 10G030 10G045 10G046 10G047 10G050 10G051 10H016 10H018 10H087 10H094 10J053 10J058 10J062 10J102 10K026 10K035 10K039 10K086 10M023 10M040 10M043 10M045 10F020 10F087 10H086 10H095 10J017 10J020 10J056 10J068 10K021 10K029 10K031 10K081 10K105 10M017 10M039 10J052 10K098 10F064 10H044 10K022 10K042 10F024 10F025 10F033 10F055 10F062 10F063 10F065 10H005 10H030 10H042 10J015 10J019 10J061 10J065 10K032 10K037 10K095 10M030 10M087 10M098 10M099 10M100 Expiration Date: 06/30/13
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAGAMBRO Capillary Dialyzer, Polyflux(R) Revaclear MAX, STERILE, Product code 110634 Product Usage: TheNovember 16, 2016
- FDASynovis VASCU-GUARD Peripheral Vascular Patch in the following sizes and product codes: 1 cm x 6 cm, productAugust 24, 2016
- FDA0.9% Sodium Chloride Injection, USP, 250 mL VIAFLEX Plastic Container Bag, Rx Only, Manufactured by BaxterJune 15, 2016
- FDADextrose Injection,USP,70% 2000 mL VIAFLEX Plastic Container Bag, Pharmacy Bulk Package, Not For DirectJune 15, 2016
- FDAMultilite Dye Handpieces, an optional accessory of the RevLite SI Laser. The Revlite SI laser is intended forJuly 3, 2013
- FDABrand Name: Multirate Infusor Devices. Indicated for the intravenous administration of medications.July 3, 2013
Questions about this recall
Was Brand Name: Infusor SV and LV Elastomeric Infusion Devices. Indicated for the intravenous administration of medications. recalled?
Yes. FDA published recall Z-1600-2013 on July 3, 2013. Reported hazard: Baxter Healthcare Corporation (Baxter) is issuing an Urgent Product Recall for the products listed above due to an increase in rupture complaints. Baxter has implemented product and process improvements which have substantially improved product quality. Complaint rates for ruptures have since decreased. Baxter wants to ensure that no affected product remains in the field.
What should I do if I have this product?
Voluntary: Firm initiated · Letter